Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-1999 | 03-1999 | 12-1998 | 09-1998 | 06-1998 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,670 | -1,270 | -2,650 | -980 | -520 |
| Depreciation Amortization | 340 | 150 | 330 | 190 | 60 |
| Other Working Capital | -230 | 650 | 1,660 | 760 | 240 |
| Other Operating Activity | 0 | 10 | 30 | 10 | 10 |
| Operating Cash Flow | $-2,560 | $-460 | $-630 | $-20 | $-210 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4,450 | -3,020 | -5,340 | -1,760 | -260 |
| Other Investing Activity | -40 | -30 | -410 | -330 | -120 |
| Investing Cash Flow | $-4,490 | $-3,050 | $-5,750 | $-2,090 | $-380 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,130 | 4 | 810 | 470 | 40 |
| Financing Cash Flow | $1,130 | $4 | $810 | $470 | $40 |
| Beginning Cash Position | 21,570 | 21,030 | 27,020 | 26,460 | 26,810 |
| End Cash Position | 15,640 | 17,500 | 21,440 | 24,820 | 26,260 |
| Net Cash Flow | $-5,920 | $-3,520 | $-5,570 | $-1,630 | $-540 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,560 | -460 | -630 | -20 | -210 |
| Free Cash Flow | -2,560 | -460 | -630 | -20 | -210 |